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Exposure to environmental stressors, toxicants and nutrient deficiencies can affect DNA in a 
number of ways. While some exposures cause damage and alter the structure of DNA, there is 
increasing evidence that the same or other environmental exposures, including those experienced 
during fetal development in utero, can cause epigenetic effects which modulate DNA function and 
gene expression. Some epigenetic changes to DNA that affect gene transcription are at least 
partially reversible (i.e. they can be enzymatically reversed after cessation of exposure to 
environmental agents), but some epigenetic modifications seem to persist even for decades. To 
explain the effects of early life experiences (such as famine and other exposures to stressors) on the 
long-term persistence of specific patterns of epigenetic modifications, such as DNA methylation, 
we propose an analogy with immune memory. We propose that an epigenetic memory can be 
established and maintained in self-renewing stem cell compartments. We suggest that the 
observations on early life effects on adult diseases and the persistence of methylation changes in 
smokers support our hypothesis, for which a mechanistic basis, however, needs to be further 
clarified. We outline a new model based on methylation changes. Though these changes seem to be 
mainly adaptive, they are also implicated in the pathogenesis and onset of diseases, depending on 
individual genotypic background and/or types of subsequent exposures. Elucidating the 
relationships between the adaptive and maladaptive consequences of the epigenetic modifications 
that result from complex environmental exposures is a major challenge for current and future 





Epigenetic events, including DNA methylation and histone modifications, are increasingly 
recognized as key mechanisms involved in cellular responses to environmental stimuli and in the 
etiology of disease (1, 2). Here, we consider the role of DNA methylation in these processes. The 
addition of a methyl group to cytosines at CpG sites within cis-regulatory elements such as 
promoter and enhancer sequences usually leads to suppression of transcription and therefore to a 
reduced expression of the corresponding gene. The main mechanisms driving this association with 
transcription involve proteins such as MeCP2 and MBD2, which bind to methylated cytosines and 
facilitate the assembly of repressed chromatin domains. The absence of methyl-CpG-binding 
proteins at unmethylated promoters enables chromatin to maintain a relatively open configuration 
that allows transcription factors access to their cognate target sequences in DNA [3]. Reduced 
methylation may lead to genome instability, particularly if it occurs in repeat sequences such as 
LINE1 transposable elements, which have a high CpG density (4). Methylation levels in white 
blood cells (WBC) and in other tissues in humans are potentially influenced by fluctuating 
exposures induced by smoking [5], diet [6-8] or air pollution [9]. Sometimes the events involved in 
inducing changes in methylation are very remote and persist over time, such as the impact of in 
utero exposure to the Dutch famine on adult phenotype. The latter has been attributed to changes in 
gene methylation, though with small absolute changes in methylation levels and mainly in 
imprinted genes [10]. In addition to cytosine methylation, other mechanisms, involving DNA and/or 
histone modifications and small RNAs, are also implicated in epigenetic changes, but they are not 
discussed further in this paper. 
Studies in animals also point to the existence of remarkably stable DNA methylation changes that 
can be induced by exposure to nutritional, behavioural or other environmental stimuli, and which 
then persist long-term. Rodent offspring that are exposed to changes in maternal nutrition during 
fetal development or neonatally, exhibit metabolic disturbances with physiological consequences 
that are associated with stably altered patterns of DNA methylation and other epigenetic marks in 
somatic tissues (11-15). Similarly, studies of the epigenetic effects of stressful experiences in 
rodents have demonstrated changes in DNA methylation patterns associated with genes involved in 
regulating neuroendocrine signaling as a consequence of stressors experienced either during early 
life (16-18) or in adulthood (19). Direct exposure of rodents to the chemical environmental 
contaminant Bisphenol A has also been demonstrated to exert strong biological and long-lasting 
epigenomic effects through altering DNA methylation levels (20, 21). 
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Taken together, the observations on the effects of nutritional, behavioural or other environmental 
stressors [22] suggest that there are long-lasting mechanisms underlying these heritable changes that 
are transmitted across many cell generations. Here, we propose a hypothesis that DNA methylation 
is a crucial component of cellular responses to environmental signals, acting within self-renewing 
human stem cell populations that persist across the life course, which may become enriched under 
selective pressure. 
 
Hypothesis: methylation memory 
We hypothesize that a long-lasting epigenetic change FDOOHG KHUH ³HSLJHQHWLF PHPRU\´ FDQ EH
likened to the immune memory of %XUQHW¶V FORQDO VHOHFWLRQ WKHRU\ of adaptive immunity. Such 
epigenetic memory may be activated in response to changes in exposure to a wide range of 
exogenous or endogenous agents, including toxicants, nutrients, and behavioural stimuli, analagous 
to exposure to exogenous antigens from infectious pathogens. Since the resulting epigenetic 
changes are known to be observable many years after the initial stimulus or exposure, some of them  
must be embedded in stem cells since these changes persist for much longer than the lifetime of 
some of  the mature terminally differentiated cells in which they are observed (e.g. WBC or 
epithelial cells). Accordingly, we hypothesize that, just as a clone of B-cells carrying a specific 
antibody is activated and amplified in response to reinfection of the body by a pathogen bearing the 
antigen that initially generated the B-cells, so self-renewing stem cells have a similar behavior:  the 
DNA methylation status of specific genes would be altered by a particular exposure early in life and 
may persist in a state of primed responsiveness and alter transcription of these genes,- allowing 
rapid adequate cellular responses if the same or a related exposure occurs at a later time. Cells 
which have been epigenetically primed to respond effectively to renewed stimulus exposure would 
be expected to have a growth/survival advantage which would promote their clonal expansion. For 
example, such epigenetic changes predisposing genes involved in detoxification to rapid and high 
levels of transcription would be positive adaptive responses that enhance cellular and organismal 
survival if individual genotypic background is favorable.   
Antibodies are continuously produced via somatic hypermutation and V(D)J recombination in B-
cells. The renewed encounter with a specific antigen leads to clonal amplification of the B-cell that 
carries the corresponding antibody. In the case of detoxification of exogenous or endogenous 
agents, we hypothesize that repeated encounters of key cell regulatory molecules (e.g. receptor 
proteins such as AhR - see below) with such agents lead to persistent DNA methylation changes 
which place AhR-responsive detoxifying genes in a transcriptionally activated or activation-
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competent state. We suggest that changes in the patterns of CpG methylation associated with such 
genes persist as adaptive epigenetic memories within stem cell compartments that can be activated 
and amplified by clonal expansion when the toxicant or other stimulus is subsequently re-
encountered. Such beneficial epigenetic memories could then render cells competent to mount more 
rapid and effective transcriptional responses to environmental stimuli, including beneficial stimuli 
such as dietary. This hypothesis recognizes that whilst these epigenetic modifications may enable 
mature, differentiated non-proliferative tissues to respond to an exposure to a stimulus directly, it 
also postulates that persistence of an epigenetic memory of exposure in stem cells could enable the 
rapid production, mobilization and potentially widespread dissemination of differentiated cells with 
beneficial capabilities. 
Whilst exposure to particular toxicants may introduce into stem cells epigenetic changes that 
modify the transcriptional capabilities of genes that are specifically toxicant-responsive, other 
environmental circumstances, such as nutrient deficiencies, may affect the global methylation status 
of cells, including stem cells and their differentiated, post-mitotic progeny. For example, reduced 
availability of nutrients that support one-carbon metabolism such as methionine, choline, betaine 
and folate can cause global hypomethylation and also effects on specific CpGs.  
Global hypomethylation, frequently observed following toxic exposures and nutritional 
deficiencies, may in fact constitute a general cellular response that may render all or many inactive 
genes primed for activation, and favour increased transcription of already active loci. Such 
transcriptional plasticity could facilitate the global re-calibration of cellular phenotypes to 
accommodate altered circumstances, which might be necessary in times of toxic stress or nutrient 
restriction, for example. Since the broad phenotypic plasticity of pluripotent stem cells in the 
mammalian embryo is due, at least in part, to global hypomethylation (23), it is possible that the 
presence of hypomethylated loci in adult stem cell reservoirs in adult organs may also confer 
broader sensitivity to exposures arising in sub-optimal environments. Moreover, should nutritional 
circumstances improve, the induced phenotypic plasticity of stem cells could facilitate further 
adaptive responses more effectively than post-mitotic cells in which phenotypic plasticity might be 
limited. Stem cells carrying unmethylated CpGs could thus EHVHOHFWHGWRPDLQWDLQDQ³DOHUW´VWDWXV
following a situation of deficiency, in readiness to respond protectively in case of future re-
encounters with similar environmental challenges or threats. Whilst such long-lived epigenetic 
changes would tend to serve a beneficial/protective purpose, it is possible that, over time, they may 
also interact with accumulated changes induced in cells by events later in life (e.g. other exposures 
or ageing), becoming maladaptative and end up contributing to disease pathogenesis. The latter 
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parallels the induction of B cell neoplasia and autoimmunity by chronic exposure to a structurally-
related exogenous antigen (24). Another mechanism could be, for nutrition, the organism being 
prepared for one nutritional environment but meeting another ± the ³mismatch´ idea. 
 
Examples of long-lasting methylation changes 
For the sake of simplicity we consider two broad types of observations on DNA methylation: 
x global hypomethylation that is frequently observed after dietary deficiency, toxic 
exposures or in pre-cancerous states (usually measured in white blood cells, WBC) 
x hypo- or hyper-methylation at specific genomic sites or pathways observed after 
exposure to toxic agents (such as tobacco smoke or bisphenol A) or in cancerous tissues. 
The first category of change we consider is a somewhat global effect produced by fundamental 
environmental challenges that affect basic biochemical and molecular processes, such as folate 
deficiency. More targeted effects on particular sites associated with single genes or pathways are 
instead the consequences of signalling by specific types of stimuli. The two mechanisms can co-
exist depending on the type of insult. We use case studies to test if such a hypothesis of a general 
and a specific methylation memory holds true for various types of challenges at various times in the 
lifecourse. 
A state of gOREDO ³K\SRPHWK\ODWLRQ´ may be induced in proliferation-competent cells that are 
exposed to a stimulus and then undergo mitosis to give rise to the tissue of interest, or alternatively, 
hypomethylation may result when a post-mitotic tissue is exposed to an environmental challenge 
(for example when measured as an average across multiple or all probes in an epigenetic-wide 
association study, EWAS, or in LINE-1 and Alu, i.e. high copy long repeat sequences). In either 
situation, detection of hypomethylation for a single probe occurs when an excess of cells (which 
may or may not arise from proliferation of stem cells) exhibits low levels of methylation at the CpG 
site contained within the probe sequence. Hypermethylation for a single probe is detected when an 
excess of cells is methylated at the corresponding CpG (Figure 1). Caution is needed when the 
possibility of global methylation is being considered, because we currently have only a partial 
understanding of the extent to which a generalized hypomethylation process may be similar across 
tissues and indeed the extent to which such hypomethylation is fully genome-wide: most studies of 
methylation at specific sites do not consider genuinely global changes because many of the 
epigenome-wide techniques (e.g. the Illumina 450K array) have limited coverage, so that the 
possibility of specific effects occurring at some CpG sites are difficult to rule out. Therefore, whilst 
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there is mounting evidence that some exposures induce broadly global changes in methylation 
patterns, and that other exposures elicit more specific changes within the epigenome by targeting a 




1. Global hypomethylation and altered one-carbon micronutrient availability 
Global DNA hypomethylation is known to result from deficiencies either in methyl group 
availability or in enzymes responsible for DNA methylation. Nutrients involved in one-carbon 
metabolism, such as folate, methionine, vitamin B12, choline and betaine, play critical roles in 
determining methyl group availability and in maintaining DNA methylation. Folate, a water soluble 
B vitamin, aids in the transfer of one-carbon units and is involved in multiple cellular processes, 
including specific amino acid synthesis, DNA replication and DNA methylation. It cannot be 
synthesized de novo by mammalian cells and, therefore, its cellular level depends on dietary intake. 
Folate deficiency alters the balance of the pool of nucleotides needed for the synthesis of DNA, 
leading to dUMP accumulation/misincorporation in DNA and thus potentially to chromosomal 
changes and genetic instability. Of relevance for DNA methylation, folate also plays an important 
role in the synthesis of methionine as a cofactor for the enzyme methionine synthetase. Methionine 
is a precursor of S-adenosyl methionine (SAM), the universal methylation donor required for the 
methylation reaction catalyzed by DNA methyltransferases (DNMTs). Thus, factors that limit SAM 
supply could have an important impact on DNA methylation and histone methylation. Global 
hypomethylation resulting from reduced supplies of one-carbon nutrients may create a state of 
transcriptional permissiveness that renders tissues more readily responsive to external factors. This 
state may then enable epigenomic adaptations that could, for example, facilitate more efficient, or 
³WKULIW\´ utilisation of scarce nutrients. Moreover, global DNA hypomethylation may constitute a 
background of hypomethylation, not significant at that level, but which favors overriding of the 
threshold for gene transcription, if an additional DNA hypomethylation or epigenetic change occurs 
at a specific gene in a given tissue.   
Recent studies of the seasonal variation in the one carbon micronutrient intake of mothers at the 
time of conception further demonstrate a strong link between folate, betaine, choline and 
methionine availability and the establishment and long-term persistence of distinct patterns of DNA 
methylation in offspring (25, 26). In these studies, variable patterns of DNA methylation established 
in the early embryo were found to persist in infants at many different loci WHUPHG ³metastable 
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epialleles´ in a manner that reflected one carbon micronutrient availability to mothers at the time of 
offspring conception. In a population based study of two European cohorts, a significant association 
was observed between maternal plasma folate levels during pregnancy and genome-wide patterns of 
DNA methylation in newborns (27). Consistent with these findings, it has been suggested that 
maternal nutrition contributes a ³metabolic imprint´ to the offspring epigenome during embryonic 
development, which then persists in progeny over the long-term as a pattern of metastable epialleles 
(28).  
 
2. Exposure to Bisphenol A and patterns of DNA methylation and gene transcription 
Bisphenol A (BPA) is a chemical which has multiple effects on gene methylation. It is widely used 
in the chemical synthesis of epoxy resins and polycarbonate plastics and is a ubiquitous 
environmental contaminant, implicated in endocrine disruption and increased risks for disorders of 
the nervous, immune and reproductive systems, including cancer and obesity. As a stable ligand for 
oestrogen and other steroid hormone receptors, BPA exerts appreciable effects on animal and 
human fertility, and in experiments to investigate its epigenetic effects, it has well-characterized 
impacts on DNA methylation that affect the expression of many genes. The adverse effects of 
maternal BPA exposure on offspring are strong when exposure occurs either during gestation or 
postnatally during lactation, and they persist in the tissues of progeny as metastable epialleles, long 
after the period of exposure has ended (20), suggesting that this compound may exert a substantial 
impact on the epigenetic programming of developing tissues and/or in stem/progenitor cells. Global 
methylation analysis suggested that BPA increases the overall levels of genomic methylation by 
~15% (29), although more detailed studies of the epigenomic effects of BPA - focusing on 
transcription units and associated regulatory sequences - revealed that in the liver, whilst a large 
number of genes are hypermethylated in response to BPA, many others are hypomethylated (30). A 
similarly complex picture has emerged from studies of the effects of BPA in the brain, where 
sex-specific, brain region-specific increases and decreases in DNA methylation levels have 







3. Smoking-associated hypomethylation  
In addition to global or generalized changes, we propose a model in which environmental exposures 
to toxicants can elicit distinct long-term and shorter-term impacts on patterns of DNA 
hypomethylation at specific loci. This proposal is based on observations related to smoking, an 
exposure with broad and well-characterised health effects (32), which we use here as a case study. 
In a series of studies on tobacco smoking we found that hypomethylation of several genes in WBC 
and also in lung tissue of healthy subjects was associated with smoking (33-37). This finding has 
been replicated in many other studies of WBC, buccal cells and cord blood of smoking mothers (38-
50). To investigate the dynamics of methylation in smoking we conducted epigenome-wide 
analyses in a population sample of 1,000 subjects [36]. When we examined the distribution of 
methylation changes by time since smoking cessation we observed the pattern reported in Figure 2. 
While for many CpGs, methylation reverted back to levels of never-smokers, for other CpGs 
hypomethylation was still present after 30-40 years since smoking cessation. The stability of some 
of these methylation changes is not compatible with the short half-life (death/replication rate) of 
WBC, and instead suggests that long-term changes to patterns of DNA methylation are induced in 
hematopoietic stem cells of the bone marrow by exposure to tobacco smoke, which then persist in 
the stem cell compartment for decades and are transferred to differentiated, circulating progeny of 
these stem cells even after smoking cessation.  
The gene that was most affected by methylation changes in the majority of these studies was AHRR, 
encoding the repressor of the Ah Receptor (AhR), that in turn regulates transcription of specific 
target genes in response to cell-permeable toxicants from the external environment. In our study we 
found that the list of CpGs with persistent tobacco-induced methylation changes included a number 
of CpGs associated with the AHRR locus. We also compared methylation levels of 49 AHRR probes 
in WBC with methylation in lung macrophages from the literature, finding that the effect of 
smoking was broadly similar in the two tissues (Figure 3), with most CpGs being hypomethylated 
in current smokers and former smokers compared to never smokers, despite the large difference in 
baseline expression levels (very low in WBC, high in lung macrophages). AHRR expression was 
upregulated by smoking in both tissues. In a mouse model of smoking we observed an initial 
decrease in expression of AHRR at 3 days of exposure and a significant increased expression after 
longer-term exposure (28 days) [36]. These observations provide a clear example of a gene-specific 
transcriptional regulatory pathway activated by the exposure and a gene-specific epigenetic 
hypomethylation pattern that exhibits long-term persistence, most likely in hemopoietic stem cells, 




4. Multiple methylation and transcriptional changes in ex-smokers 
 
It is likely that the prominent methylation changes in the AHRR gene are consequences of exposure 
to a particular class of toxicants/carcinogens in tobacco smoke. The obvious candidates are 
polycyclic aromatic hydrocarbons, including benzo(a)pyrene, which bind to AhR and are likely to 
be involved in lung carcinogenesis according to mutational signatures (Alexandrov et al, 
submitted). However, tobacco smoke is a very complex mixture and has a range of different 
impacts on health (including cardiovascular disease) and therefore it is likely that a more complex 
epigenetic reaction/adaptation is elicited than simply AHRR hypomethylation.   
We have conducted a preliminary evaluation of the implications of long-lasting CpG-methylation 
changes by focusing on genes harboring CpG sites with significant methylation changes surviving 
for at least 10 years post-smoking cessation (518 CpGs; 339 unique genes) [36]. Bioinformatics 
analysis of these genes (unpublished results) yielded the list of significant gene ontology (GO) 
terms shown in Table 1, which can be interpreted as UHIOHFWLQJWKHFHOO¶VHSLJHQHWLFDOO\-determined 
readiness for the upregulation of various categories of interacting cellular pathways and processes 
which influence cellular fate. It is noted that GO terms reflect not only the specific states or 
processes after which they are named but also underlying cellular activities of mechanistic 
relevance, and should be interpreted as such. For example, the top WHUPLQ7DEOH³growth plate 
FDUWLODJH GHYHORSPHQW´) is a developmental term implicating cell matrix and stroma interactions, 
fundamental components of the wound healing response. The GO terms identified are linked to a 
number of genes with global regulatory impact as judged by the number of functions to which they 
are associated (hub genes), some of which suffer substantial demethylation in smokers as well as 
ex-smokers for >10 years. These GO terms and associated hub genes relate to: 
- development and morphogenesis, with a prominent role for genes like the retinoic acid receptors 
RARA and  RARG, coupled by the differentiation-inducing SMAD interacting proteins to 
TGFBR2, the proto-oncogene SKI, the hedgehog/WNT signalling induced gene CSRNP1 and the 
histone demethylase ARID5B; 
- activation of metabolism and protein synthesis, including broad metabolic (ASNS, NFE2L2), 
transcriptional (RARG, VIM, E2F1, TNF, ATF4) and translational (RPS18, RPL12, RPL23A, 
EEF1D) alertness, protective nonsense-mutated mRNA decay (SMG6), all of which reflect the 
FHOO¶VVWDWHRILQFUHDVHGUHDGLQHss to respond to future stress; 
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- response to oxidative stress/detoxification of free radicals (key genes involved: GPX, NFE2L2, 
responsive to AhR signaling) and anti-apoptosis ± it is noted that suppression of oxidative stress-
induced apoptosis, constitutes a fundamental mode of defence against toxicant-induced cell death; 
- differentiation and wound healing (TGFBR2, INHBA, GDF11, SMAD3, NFE2, SKI), regulation 
of the cell cycle and proliferation (CDKN1A, MINK1, AKT1) and, particularly interesting, 
stemness (SKI, PIM3, RALA, RRAS, TNFAIP8, PURA), reflecting the induction of stem cell-like 
properties as being necessary for tissue repair; angiogenesis (ATOH8, NFE2L2, NFE2), 
inflammation (TNFAIP, TNF) and immune response modulation (CD44, BCL3, THBS1, MYO1G), 
which are fundamental components of the wound-healing process. 
The potential upregulation of cellular metabolism-UHODWHG SURFHVVHV HJ ³SRVLWLYH UHJXODWLRQ RI
JHQH H[SUHVVLRQ´ ³WUDQVODWLRQDO HORQJDWLRQ´ ³SRVLWLYH UHJXODWLRQ RI UHDFWLYH R[\JHQ VSHFLHV
PHWDEROLF SURFHVV´ HQWDLOV LQFUHDVHG HQHUJ\ GHPDQGV DQd would therefore be subject to strong 
thermodynamic restrictions depending on the energy available to cells, as reflected in the GO term 
³FHOOXODUUHVSRQVHWRJOXFRVHVWDUYDWLRQ´Finally, the potential for increased growth and/or survival 
is reflected in the GO terms «regulation of mitotic cell cycle», «positive regulation of programmed 
cell death» and « negative regulation of apoptotic process». This is consistent with the idea that 
persistent hypomethylation in stem cells, by facilitating cellular responses to subsequent exposures 
by readiness to transcribe relevant genes in daughter cells, promotes clonal expansion in mitotic 
cells via increased proliferation rate and/or reduced apoptosis frequency. Thus the overall picture of 
the long-lived smoking-induced epigenetic changes suggests the establishment of a multi-layered, 
spatially and temporally emergent, homeostatic response phenotype.  
 
Discussion 
The significance of global hypomethylation in different tissues (i.e. an altered ratio between cells 
carrying unmethylated vs.4 methylated CpGs) is still not well understood. We suggest that global 
hypomethylation is a cellular response to changes in nutritional circumstances such as famine, lack 
of nutrients such as folate, or other systemic environmental challenges. A causal relationship 
between hypomethylation and dietary shortage in, for example, methionine, folate, vitamin B12 and 
choline, is supported by the evidence reviewed above. Dietary factors may thus influence the supply 
of methyl groups available for the formation of S-adenosylmethionine (the co-enzyme involved in 
methyl group transfer) or modify the utilization of methyl groups. Moreover global systemic DNA 
hypomethylation may favor exceeding the threshold for gene expression if an additional epigenetic 
change occurs in specific genes of a given tissue. 
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Perhaps the most intriguing finding so far has come from the study of the long-term effects of 
tobacco smoke through an epigenome-wide methylation approach. The Ah Receptor (AhR) is well 
known for regulating responses to an array of environmental chemicals. A growing body of 
evidence suggests that the AhR also plays a key role in modulating critical aspects of cell function 
including cell growth, death, and migration [51]. AHRR is highly conserved in evolution [51]. 
While its most studied function is the mediation of the effects of exogenous chemicals such as 
dioxin and PAHs on the cell [52], AHRR is also involved in many other functions including the 
effects of tobacco smoking in pregnancy (53, 54). AhR is antagonized by the preventive agent and 
antioxidant resveratrol [55]. The studies we conducted in smokers were in white blood cells, 
implying that epigenetic ³PHPRU\´ elicited by smoking was likely established in hematopoietic 
stem cells. However, we also investigated the lung tissue of smokers and non-smokers. Methylation 
levels of the AHRR JHQHSUREHVZHUHVLJQL¿FDQWO\GHFUHDVHG 3 DQGH[SUHVVLRQ LQFUHDVHG
(P=0.0047) in the lung tissue of current smokers compared with non-smokers (36). This was further 
validated in a mouse model of smoke exposure with similar results (36). There is no data yet on the 
lungs of ex-smokers. 
It is likely that the prominent methylation changes in the AHRR gene are the expression of a 
particular class of toxicants/carcinogens, particularly benzo(a)pyrene, that bind to AhR and leave 
characteristic mutational signatures also found in lung cancer cells (Alexandrov et al, submitted). 
However, tobacco smoke is a very complex mixture with a range of different impacts on health and 
therefore it is likely that a more complex epigenetic reaction is elicited. This is in fact what we have 
observed by bioinformatic analysis of ex-smokers. Seen in the above context, the long-lived 
epigenetic changes induced by smoking can be thought of as serving the role of long lasting 
memory, providing an optimized pool of adaptive scenarios to tissue damage. On the other hand, 
because of their stochastic nature, these responses are also subject to disruption by detrimental 
structural events (mutations, insertions, deletions) which may arise from various exposures 
including smoking and which would determine whether they ultimately serve an adaptive or a 
maladaptive role. For example, the disruption of the balance between inherited genetic background, 
developmental, differentiating, immune regulatory and inflammatory stimuli during the wound 
healing process, by the induction of mutations in critical genes as a result of exposure to mutagens, 
may provide the basis for establishment of oncogenic niches. The latter may result in an aberrant 
deviation of the healing process, turning the induction of stemness from a potentially beneficial 
adaptation into a maladaptive (carcinogenic) response. Also, whereas suppression of apoptosis 
would protect the individual cell from toxicant-induced death, in the presence of mutations it could 




DNA methylation changes DV³UHDGLQHVV´for plastic responses  
There is still limited evidence that an exposure may cause a similar pattern of gene-specific 
methylation changes in different tissues, regardless of the gene's tissue-specific expression (see in 
particular the example of AHRR in WBC and lung). While the generality of such a phenomenon is 
currently unknown, a similarity across tissues may reflect the presence of common, locus-specific 
elements of chromatin architecture related to the operation of common gene regulatory networks 
across tissues that are more highly connected in functional terms than within-tissue transcriptional 
regulatory networks (56-58). Accordingly, we hypothesize that the pattern of DNA methylation 
changes following a particular exposure, and their persistence, extends to other tissues (especially in 
stem cells), including tissues that constitute targets for exposure-related disease.  
The mechanisms linking DNA methylation and gene expression (e.g. demethylation in promoter 
CpGs being associated with increased transcription) involve many players in addition to the DNA 
methylation enzymes and methyl-CpG binding proteins, e.g. histone-modifying proteins, chromatin 
remodeling enzymes, other forms of methylation than just cytosine, and sequence-specific DNA 
binding-transcription factors. Thus, modulation of DNA methylation constitutes for the cell a means 
of producing heritable changes that can prime genes for transcription activation events that may not 
necessarily be initiated immediately, and which may be reversed if the need arises. An additional 
characteristic of DNA methylation is that its alteration at multiple CpG sites is usually necessary in 
order for change in expression to occur, thus providing cells with a means of modulating their levels 
of readiness for adapting gene expression. For example, one may speculate that the long persistence 
of the majority of the AHRR-associated CpGs modified by tobacco smoking (13 of a total of 20 
tobacco-modified CpGs remained hypomethylated and 1 hypermethylated for up to 47 years after 
smoking cessation; ref. 36) may provide the cell with a mechanism of quickly re-activating 
epigenetic control of expression of this key regulatory gene if the need arises, by completing the 
methylation changes of the remaining CpGs. Therefore exposure-induced methylation changes can 
"prepare the ground" without automatically leading to significant changes in expression unless 
additional conditions are fulfilled, something that may occur in different tissues and at different 
times. When such conditions eventually arise in target tissues, in combination with the existing, 
altered methylation pattern, they then lead to significant changes in expression.  
Taken together, the studies of the long-term epigenetic effects of exposure to environmental agents 
in early life, such as famine, micronutrient availability and chemical toxicants such as tobacco 
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smoke or Bisphenol A, suggest that self-renewing stem cell reservoirs in developing and adult 
tissues can acquire epigenetic memories that are adaptive, conferring additional elements of 
phenotypic plasticity to multipotent cells that enable beneficial responses to subsequent exposures. 
However, the broadening of phenotypic plasticity in stem cells by environmental exposures may 
also be maladaptive if subsequent exposures are encountered that increase cell vulnerability to 
disease-causing phenotypic changes or further destabilize stem cell identity in ways that extinguish 
self-renewal and/or multipotency. Conrad Waddington originally recognized that developmental 
processes are buffered against some environmentally-induced or stochastic phenotypic changes, 
through a genetically determined process he termed canalization (59). However, the phenotypic 
robustness produced by canalization can be compromised by mutations in developmental regulatory 
genes, some of which are now known to encode components of epigenetic mechanisms that regulate 
gene transcription. The chaperone protein Hsp90, for example, has been identified as a suppressor 
of phenotypic variation in many eukaryotes, through its regulatory interactions with a wide range of 
client proteins that are involved in the regulation of signaling pathway activities and epigenetic 
processes (60, 61). Nevertheless, even though canalization promotes robustness, many 
developmental and physiological processes still remain sensitive to environmental signals. A key 
challenge for future research is therefore to elucidate the processes that engender adaptive and 
maladaptive (disease-causing) epigenetic changes in response to environmental exposures. In 
particular, further studies are warranted of the roles of DNA methylation and other forms of 
chromatin modification in mediating the impacts of salient environmental stimuli, including 
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Term id Term Definition Enrichmen
t 
p-value corrd p 
1 GO:0003417 growth plate cartilage development 4/8 3.6730e-5 0.0028 
2 GO:0006928 movement of cell or subcellular 
component 
10/87 0.0001 0.0041 
3 GO:0043154 negative regulation of cysteine-type 
endopeptidase activity involved in 
apoptotic process 
9/77 0.0003 0.0059 
4 GO:0006414 translational elongation 10/101 0.0005 0.0086 
5 GO:1902176 negative regulation of oxidative 
stress-induced intrinsic apoptotic 
signaling pathway 
4/15 0.0006 0.0110 
6 GO:0042149 cellular response to glucose 
starvation 
5/28 0.0009 0.0141 
7 GO:0030168 platelet activation 15/212 0.0009 0.0147 
8 GO:0043068 positive regulation of programmed 
cell death 
3/8 0.0011 0.0156 
9 GO:0045599 negative regulation of fat cell 
differentiation 
6/43 0.0011 0.0202 
10 GO:0007265 Ras protein signal transduction 8/76 0.0012 0.0205 
11 GO:0060395 SMAD protein signal transduction 7/60 0.0013 0.0214 
12 GO:2000379 positive regulation of reactive 
oxygen species metabolic process 
5/32 0.0017 0.0224 
13 GO:0060325 face morphogenesis 5/34 0.0023 0.0301 
14 GO:0007346 regulation of mitotic cell cycle 7/71 0.0034 0.0304 
15 GO:0060021 palate development 7/75 0.0046 0.0305 
16 GO:0046685 response to arsenic-containing 
substance 
3/13 0.0048 0.0334 
17 GO:0010628 positive regulation of gene 
expression 
16/280 0.0052 0.0350 
18 GO:0007266 Rho protein signal transduction 6/59 0.0056 0.0360 
19 GO:0043066 negative regulation of apoptotic 
process 
25/527 0.0068 0.0404 
20 GO:0006415 translational termination 7/88 0.0109 0.0415 
21 GO:0000184 nuclear-transcribed mRNA 
catabolic process, nonsense-
mediated decay 
9/119 0.0058 0.0430 
22 GO:0032147 activation of protein kinase activity 6/62 0.0072 0.0445 
23 GO:0007369 Gastrulation 4/32 0.0112 0.0476 









Figure 2- Distribution of probe-specific methylation changes (number of perturbed probes, 
mainly hypomethylated, on vertical axis) according to time in years since smoking cessation 
(on horizontal axis). Stronger hypomethylation (vertical axis) is closer to smoking cessation. 
Increasing methylation levels approach those of never smokers several years after smoking 
cessation. After many years the number of signals levels-off, suggesting the existence of sites 
whose methylation status remains altered even more than 35 years after smoking cessation. 
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